Abstract
Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Current Cancer Therapy Reviews
Title:Treatment Decisions for Non-Melanoma Skin Cancer (NMSC)
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai, Arbind Dubey, Rashmi Koul and Elizabeth A. Barnes
Affiliation:
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Abstract: Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia, Dubey Arbind, Koul Rashmi and Barnes A. Elizabeth, Treatment Decisions for Non-Melanoma Skin Cancer (NMSC), Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160921151835
DOI https://dx.doi.org/10.2174/1573394712666160921151835 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs
Current Pharmaceutical Biotechnology Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy
Current Pharmaceutical Design Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology Ultrasound-Directed Drug Delivery
Current Pharmaceutical Biotechnology Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.
Current Pharmaceutical Design Optical Image-Guided Cancer Therapy
Current Pharmaceutical Biotechnology Restoration of Chemoresistance Mechanism by Novel Drug Therapies in Breast Cancer Cell Lines
Current Drug Therapy Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries
Current Pharmaceutical Design From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry New Perspectives for Melanoma Immunotherapy: Role of IL-12
Current Molecular Medicine Anti-Immunoglobulin E Treatment with Omalizumab in Allergic Diseases an Update on Anti-Inflammatory Activity and Clinical Efficacy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Drug Repurposing in Human Cancers
Current Medicinal Chemistry Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges
Current Stem Cell Research & Therapy Amphiphilic Oligomers: A New Kind of Macromolecular Carrier of Antimitotic Drugs
Current Medicinal Chemistry - Anti-Cancer Agents Lentiviral Vectors for Anti-Tumor Immunotherapy
Current Gene Therapy Exploring Pharmacological Significance of Chalcone Scaffold: A Review
Current Medicinal Chemistry RNAi in Clinical Studies
Current Medicinal Chemistry <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies